Ake P. Elhammer
Directeur Général chez AureoGen, Inc.
Profil
Ake P.
Elhammer is the founder of AureoGen, Inc. (founded in 2003) and serves as the Chief Executive Officer since 2011.
Currently, Dr. Elhammer holds the position of Professor at Western Michigan University.
Previously, Dr. Elhammer worked as a Principal at The Upjohn Co. and Kabigen AB.
Dr. Elhammer obtained undergraduate and doctorate degrees from the University of Stockholm.
Postes actifs de Ake P. Elhammer
Sociétés | Poste | Début |
---|---|---|
AureoGen, Inc.
AureoGen, Inc. BiotechnologyHealth Technology AureoGen, Inc. develops a novel genetic-engineering technology for the discovery and production of cyclic peptide based drugs. It focuses on chemical modification of cyclic peptide lead compounds, non-ribosomal peptide synthetases engineering, and chemo-enzymatic synthesis. The company was founded by Ake P. Elhammer and Jerry L. Slightom on August 12, 2003 and is headquartered in Kalamazoo, MI. | Directeur Général | 12/08/2003 |
Western Michigan University | Corporate Officer/Principal | 08/02/2010 |
Anciens postes connus de Ake P. Elhammer
Sociétés | Poste | Fin |
---|---|---|
Kabigen AB | Corporate Officer/Principal | - |
The Upjohn Co. | Corporate Officer/Principal | - |
Formation de Ake P. Elhammer
University of Stockholm | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
AureoGen, Inc.
AureoGen, Inc. BiotechnologyHealth Technology AureoGen, Inc. develops a novel genetic-engineering technology for the discovery and production of cyclic peptide based drugs. It focuses on chemical modification of cyclic peptide lead compounds, non-ribosomal peptide synthetases engineering, and chemo-enzymatic synthesis. The company was founded by Ake P. Elhammer and Jerry L. Slightom on August 12, 2003 and is headquartered in Kalamazoo, MI. | Health Technology |
The Upjohn Co. | Health Technology |
Kabigen AB |